Optometric Office

MAR 2016

Products and their applications for optometry.

Issue link: https://optometricoffice.epubxp.com/i/647235

Contents of this Issue


Page 20 of 35

Avenova from NovaBay Pharmaceuticals is the only lid and lash hygiene product that contains Neutrox, pure 0.01% hypo- chlorous acid (HOCl) in saline, that can be used for daily lid and lash hygiene. HOCl is a naturally occurring chemical gener- ated by neutrophils inside our bodies and is part of our natural defense mechanism. Neutrox is non-toxic to our tissues. In so- lution, laboratory testing demonstrates that it is effective against a broad range of organisms, including all common skin bacteria, yeast and fungi. LID BIOBURDEN Many ocular complications, including ocular rosacea, meibomian gland dys- function (MGD) and contact lens-related keratitis, are attributed to over growth of organisms on the lid margins. Indeed, one recent study found a five times greater risk for corneal infiltrative events in con- tact lens wearers when there was a sig- nificant bioburden on the lids. Increased lid bioburden can lead to an unstable tear film, which can induce symptoms of dry eye and poor or fluctuating vision. It can also cause damage of the lids and cornea resulting in inflammation-induced telan- giectasia, lid notching, misdirected lashes, scarring of the cornea, corneal irregular- ity, and in rare cases, corneal perforation. LID HYGIENE In patients with these conditions, lid hy- giene should be taught as a continual pro- cess of self-care similar to brushing one's teeth. It is much easier to prevent biobur- den-related inflammation than to treat the symptoms. Treatment options for inflam- mation predominantly include the use of steroids, which have known side effects including an increase in intraocular pres- sure, cataract formation and thinning of the dermal tissue. Avenova is fast, easy to use and does not have the drying effects of other lid hygiene products, such as the surfactant cleaners in lid scrub products or baby shampoo. There is no burning or stinging associated with product use, and therefore compli- ance remains high. Available through a prescription, it should be wiped on the lid margins one to two times a day and should be used before inserting and after remov- ing contact lenses. For makeup wearers, it is applied after makeup is removed. In cases where there is significant lid debris or collarettes, a polar oil, such as coconut oil, can be used to soften and remove mat- ter prior to application. Patients at risk for developing blephari- tis, contact lens wearers, those with dry eye symptoms, rosacea, meibomian gland dys- function and pre/peri-operative patients are all great candidates for Avenova. As part of a lid hygiene regimen, Avenova may help outcomes for comfort and vision. OO Christine W. Sindt, OD, FAAO, is clinical associate professor of oph- thalmology and visual sciences at University of Iowa Carver College of Medicine, Iowa City, IA. By Christine Sindt, OD, FAAO Avenova provides long-term comfort for patients with chronic conditions such as MGD, blepharitis, dry eye and more. An Rx for Healthy Lashes and Lids CLOSEUP Avenova contains Neutrox, pure 0.01% hypochlorous acid (HOCl) in saline. * WHERE TO FIND IT: NovaBay Pharmaceuticals, Inc. 800-890-0329 | avenova.com | sales@novabay.com o p t o m e t r i c o f f i c e . c o m | M a r c h 2 0 1 6 19 Comments From the Docs: "We have been using Avenova with our blepharitis patients for quite some time, and it has become my go-to therapy for this condition. It is gentle enough on the lids but strong enough to eradicate the problem and keep it under control." –John L. Schachet, OD, Englewood, CO "Avenova has quickly become a foun- dational treatment for the majority of my patients with ocular surface disease. I find it most useful in pa- tients with seborrheic and demodex blepharitis. The feedback I receive regarding comfort parallels the clini- cal picture within the first few weeks of daily use." – Ahmad M. Fahmy, OD, FAAO, Dipl. ABO, Minneapolis, MN

Articles in this issue

Links on this page

Archives of this issue

view archives of Optometric Office - MAR 2016